Company Announcement no. 05/2026 Annual General Meeting 2026 Copenhagen, March 27, 2026 Annual General Meeting in cBrain A/SWednesday, April 29,…
Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation…
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 11, 2026, at 10:00 a.m. CET at the…
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to pursue…
Company announcement no. 32 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to…
In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company announces a new financial ambition with organic revenue…
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an…
July 14, 2025 02:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – H1 2025…
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…